REBIF
REBIF
Discontinued
DIN Number
02277492
Drug Class
Human
Market Date
May 30, 2006
Company
HC
emd serono, a division of emd inc., canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02277492
AIG Number0131806005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L03AB07 INTERFERON BETA-1A
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
INTERFERON BETA-1AActive
Strength: 8.8 MCG / 0.2 ML
Monograph: INTERFERON BETA-1A